Sanjay Basu on affordable T2D medicine in LMICs

The Lancet Diabetes & Endocrinology in conversation with
16/11/2021 9 min
Sanjay Basu on affordable T2D medicine in LMICs

Listen "Sanjay Basu on affordable T2D medicine in LMICs"

Descargar episodio

Episode Synopsis

Sanjay Basu talks with The Lancet Diabetes & Endocrinology about what is an affordable price for newer type 2 diabetes medicines in low-income and middle-incomes countries.Read the full article:https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00240-0/fulltextContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

More episodes of the podcast The Lancet Diabetes & Endocrinology in conversation with

Roy Taylor on the causes of type 2 diabetes 20/08/2024
Ponnusamy Saravanan, Uma Ram, and Kosgei Wycliffe on early pregnancy HbA1c as a screening test for gestational diabetes 28/06/2024
Márta Korbonits on mechanisms of ageing 24/02/2023
Mirjam Christ-Crain and Cihan Atila on the patient's perspective of central diabetes insipidus 20/09/2022
Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma 19/07/2022
Rossella Nappi on menopause as a turning point for women's health 23/05/2022
Louise Baur on the causes of child and adolescent obesity 21/04/2022
Margherita Pizzato on the global epidemiological landscape of thyroid cancer 22/03/2022
Angela Titmuss on T2D in First Nations young people in northern Australia 04/02/2022
Philip Home on the centenary of insulin 15/09/2021
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA